MAREX GROUP PLC (MRX) Stock Fundamental Analysis
NASDAQ:MRX - Nasdaq - GB00BMT7GT62 - Common Stock - Currency: USD
Taking everything into account, MRX scores 4 out of 10 in our fundamental rating. MRX was compared to 237 industry peers in the Capital Markets industry. MRX has a bad profitability rating. Also its financial health evaluation is rather negative. MRX has both an excellent growth and valuation score. This means it is growing and it is still cheap. This is a rare combination!
1. Profitability
1.1 Basic Checks
MRX had positive earnings in the past year.
In the past year MRX had a positive cash flow from operations.
1.2 Ratios
MRX's Return On Assets of 1.24% is on the low side compared to the rest of the industry. MRX is outperformed by 63.29% of its industry peers.
MRX's Return On Equity of 30.81% is amongst the best of the industry. MRX outperforms 95.78% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.24% | ||
| ROE | 30.81% | ||
| ROIC | N/A |
ROA(3y)0.72%
ROA(5y)N/A
ROE(3y)16.99%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 9.43%, MRX is doing worse than 62.87% of the companies in the same industry.
MRX's Profit Margin has improved in the last couple of years.
MRX's Gross Margin of 39.71% is on the low side compared to the rest of the industry. MRX is outperformed by 64.98% of its industry peers.
MRX's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | 9.43% | ||
| GM | 39.71% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y12.13%
PM growth 5YN/A
GM growth 3Y-15.98%
GM growth 5YN/A
2. Health
2.1 Basic Checks
The number of shares outstanding for MRX has been increased compared to 1 year ago.
The debt/assets ratio for MRX has been reduced compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 0.24, we must say that MRX is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.24, MRX is not doing good in the industry: 69.62% of the companies in the same industry are doing better.
MRX has a debt to FCF ratio of 11.19. This is a negative value and a sign of low solvency as MRX would need 11.19 years to pay back of all of its debts.
MRX has a Debt to FCF ratio of 11.19. This is comparable to the rest of the industry: MRX outperforms 51.48% of its industry peers.
MRX has a Debt/Equity ratio of 10.92. This is a high value indicating a heavy dependency on external financing.
MRX has a worse Debt to Equity ratio (10.92) than 89.87% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 10.92 | ||
| Debt/FCF | 11.19 | ||
| Altman-Z | 0.24 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
MRX has a Current Ratio of 1.09. This is a normal value and indicates that MRX is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.09, MRX perfoms like the industry average, outperforming 49.79% of the companies in the same industry.
MRX has a Quick Ratio of 1.09. This is a normal value and indicates that MRX is financially healthy and should not expect problems in meeting its short term obligations.
MRX has a Quick ratio (1.09) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.09 | ||
| Quick Ratio | 1.09 |
3. Growth
3.1 Past
MRX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 39.41%, which is quite impressive.
The Earnings Per Share has been growing by 50.49% on average over the past years. This is a very strong growth
The Revenue has grown by 19.81% in the past year. This is quite good.
The Revenue has been growing by 36.98% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)39.41%
EPS 3Y50.49%
EPS 5YN/A
EPS Q2Q%50.44%
Revenue 1Y (TTM)19.81%
Revenue growth 3Y36.98%
Revenue growth 5YN/A
Sales Q2Q%-76.39%
3.2 Future
The Earnings Per Share is expected to grow by 13.80% on average over the next years. This is quite good.
The Revenue is expected to grow by 11.20% on average over the next years. This is quite good.
EPS Next Y18.58%
EPS Next 2Y13.69%
EPS Next 3Y13.8%
EPS Next 5YN/A
Revenue Next Year17.67%
Revenue Next 2Y12.19%
Revenue Next 3Y11.2%
Revenue Next 5YN/A
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 8.79, the valuation of MRX can be described as very reasonable.
80.59% of the companies in the same industry are more expensive than MRX, based on the Price/Earnings ratio.
MRX is valuated cheaply when we compare the Price/Earnings ratio to 26.41, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 9.81 indicates a reasonable valuation of MRX.
MRX's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. MRX is cheaper than 74.68% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 33.87. MRX is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.79 | ||
| Fwd PE | 9.81 |
4.2 Price Multiples
Based on the Price/Free Cash Flow ratio, MRX is valued cheaply inside the industry as 91.98% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 2.18 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
MRX's earnings are expected to grow with 13.80% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.47
PEG (5Y)N/A
EPS Next 2Y13.69%
EPS Next 3Y13.8%
5. Dividend
5.1 Amount
MRX has a Yearly Dividend Yield of 1.60%. Purely for dividend investing, there may be better candidates out there.
The stock price of MRX dropped by -22.73% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
Compared to an average industry Dividend Yield of 8.15, MRX is paying slightly less dividend.
MRX's Dividend Yield is slightly below the S&P500 average, which is at 2.39.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.6% |
5.2 History
MRX has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
DPN/A
EPS Next 2Y13.69%
EPS Next 3Y13.8%
34.99
-0.42 (-1.19%)
Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)
Earnings (Next)
Inst Owners50.51%
Inst Owner Change0%
Ins Owners6.62%
Ins Owner ChangeN/A
Market Cap2.49B
Analysts81.54
Price Target52.81 (50.93%)
Short Float %5.01%
Short Ratio1.72
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.6% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years1
Div Non Decr Years1
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.61%
Min EPS beat(2)11.13%
Max EPS beat(2)18.1%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)5.52%
Min Revenue beat(2)2.3%
Max Revenue beat(2)8.73%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.03%
PT rev (3m)17.01%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)3.21%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0.27%
Revenue NY rev (3m)3.35%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.79 | ||
| Fwd PE | 9.81 | ||
| P/S | 0.78 | ||
| P/FCF | 2.18 | ||
| P/OCF | 2.14 | ||
| P/B | 2.55 | ||
| P/tB | 3.35 | ||
| EV/EBITDA | N/A |
EPS(TTM)3.98
EY11.37%
EPS(NY)3.57
Fwd EY10.19%
FCF(TTM)16.06
FCFY45.88%
OCF(TTM)16.33
OCFY46.68%
SpS44.8
BVpS13.71
TBVpS10.44
PEG (NY)0.47
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.24% | ||
| ROE | 30.81% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | 9.43% | ||
| GM | 39.71% | ||
| FCFM | 35.84% |
ROA(3y)0.72%
ROA(5y)N/A
ROE(3y)16.99%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y12.13%
PM growth 5YN/A
GM growth 3Y-15.98%
GM growth 5YN/A
F-Score6
Asset Turnover0.13
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 10.92 | ||
| Debt/FCF | 11.19 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 69.1% | ||
| Cap/Sales | 0.62% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | 379.93% | ||
| Current Ratio | 1.09 | ||
| Quick Ratio | 1.09 | ||
| Altman-Z | 0.24 |
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)64.15%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.86%
Cap/Sales(5y)N/A
Profit Quality(3y)453.15%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)39.41%
EPS 3Y50.49%
EPS 5YN/A
EPS Q2Q%50.44%
EPS Next Y18.58%
EPS Next 2Y13.69%
EPS Next 3Y13.8%
EPS Next 5YN/A
Revenue 1Y (TTM)19.81%
Revenue growth 3Y36.98%
Revenue growth 5YN/A
Sales Q2Q%-76.39%
Revenue Next Year17.67%
Revenue Next 2Y12.19%
Revenue Next 3Y11.2%
Revenue Next 5YN/A
EBIT growth 1Y-18.95%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year28.82%
EBIT Next 3Y13.77%
EBIT Next 5YN/A
FCF growth 1Y58.2%
FCF growth 3Y35.13%
FCF growth 5YN/A
OCF growth 1Y58.3%
OCF growth 3Y35.2%
OCF growth 5YN/A